(Cold Spring Harbor Laboratory) Male breast cancer (MBC) is a very rare tumor type, occurring in just 1 percent of all breast cancer cases, and the underlying genetic causes and treatment of MBC is not well understood. In a paper published in the March issue of Cold Spring Harbor Molecular Case Studies, researchers from Italy and the US describe novel genetic variants found in a hormone receptor positive (HR+) MBC patient, that are distinct from previously identified genetic variants found in 10 MBC cases.
View the full article
